Trevi Therapeutics Inc
TRVI
Market Cap$669.59M
Close$
$0.33
94.5% downside
Current Fair Value
94.5% downsideOvervalued by 94.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $669.59 Million |
|---|---|
| Enterprise Value | $652.60 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.47 |
| Beta | 0.53 |
| Outstanding Shares | 117,610,750 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -13.96 |
|---|---|
| PEG | 270.8 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -12.99 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data